H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) shares crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $22.00 and traded as high as $24.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares changing hands.
H. Lundbeck A/S Stock Down 0.0 %
The firm has a 50 day moving average price of $22.00 and a 200-day moving average price of $22.00. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.15 and a quick ratio of 0.71. The firm has a market cap of $21.91 billion, a price-to-earnings ratio of 25.00 and a beta of 0.68.
About H. Lundbeck A/S
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
Read More
- Five stocks we like better than H. Lundbeck A/S
- How Technical Indicators Can Help You Find Oversold Stocks
- Symbotic Shares Down 37%—Is It Time for Bravery or Caution?
- Dividend Payout Ratio Calculator
- High-Yield Healthcare: 3 Stocks With Strong Dividends
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Beyond the Bargain Bin: 3 Stocks Leading Discount Retail
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
